In this Section |
270472 Association between suicidal ideation and restricted activity related to chronic diseases in Korea older adultsMonday, October 29, 2012
Purpose The aim of this study is to show association between suicidal ideation and restricted activity related to chronic diseases in older Korean adults after adjusted for socioeconomic position. Methods The study sample included 3,534 Korean men and women, over 65 years of age. Subjects were classified into two groups based on their having suicidal thought or not. Results The mean age of suicidal ideation (SI) group was 73.1±0.2 years old and no suicidal ideation (no SI) group was 72.0±0.1 (p<0.01). For SI, distribution of female was 76.5%, male was 23.5% (p<0.01). The proportion of restricted activity related to chronic diseases in SI group was 62.3% and 34.5% in no SI group (p<0.01). Economic status was shown lower and education levels were shown higher in both groups (p<0.01). EuroQol index was 0.72±0.01 in SI group, and 0.87±0.01 in no SI group (p<0.01). EuroQol VAS was 58.32±0.99 in SI group, and 70.6±0.49 in no SI group (p<0.01). Sleeping time was 6.28±0.07 in SI group and 6.54±0.04 in no SI group (p<0.01). After adjustment for age, sex, socioeconomic position, EuroQol index, EuroQol VAS and sleeping time, ORs of restricted activity related to chronic diseases was 1.61 (95% CI 1.29-2.02). Conclusion Statistical analyses from this community-based, random sample drawn from a selected sample of the Korean population demonstrate that restricted activity related to chronic diseases appears to be significantly associated with suicidal ideation in Korean older adults.
Learning Areas:
Chronic disease management and preventionLearning Objectives: Keywords: Suicide, Aging
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I designed, and analyzed this study. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 3277.0: Chronic Disease Management Issues
|